SpyGlass Pharma Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2026 | 8.02 M | $207.83 M | 100.00% | 40.25% |
| NEA MANAGEMENT COMPANY, LLC | 05/15/2026 | 7.39 M | $191.53 M | 100.00% | 37.10% |
| SANDS CAPITAL VENTURES, LLC | 05/08/2026 | 2.50 M | $64.78 M | 100.00% | 12.55% |
| SAMSARA BIOCAPITAL, LLC | 05/15/2026 | 2.11 M | $54.67 M | 100.00% | 10.59% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 704.44 K | $18.25 M | 100.00% | 3.54% |
| VESTAL POINT CAPITAL, LP | 05/15/2026 | 666.76 K | $17.28 M | 100.00% | 3.35% |
| JPMORGAN CHASE & CO | 05/13/2026 | 577.11 K | $13.49 M | 100.00% | 2.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2026 | 550.00 K | $14.25 M | 100.00% | 2.76% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 468.79 K | $12.15 M | 100.00% | 2.35% |
| 05/15/2026 | 434.81 K | $11.27 M | 100.00% | 2.18% | |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 05/15/2026 | 375.00 K | $9.72 M | 100.00% | 1.88% |
| FRANKLIN RESOURCES INC | 05/13/2026 | 300.00 K | $7.77 M | 100.00% | 1.51% |
| AFFINITY ASSET ADVISORS, LLC | 05/14/2026 | 250.00 K | $6.48 M | 100.00% | 1.25% |
| ABRDN PLC | 04/29/2026 | 220.45 K | $5.71 M | 100.00% | 1.11% |
| BLACKROCK, INC. | 05/13/2026 | 144.74 K | $3.75 M | 100.00% | 0.73% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 126.54 K | $3.28 M | 100.00% | 0.64% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 05/13/2026 | 95.00 K | $2.46 M | 100.00% | 0.48% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 59.78 K | $1.55 M | 100.00% | 0.30% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 59.61 K | $1.54 M | 100.00% | 0.30% |
| ALYESKA INVESTMENT GROUP, L.P. | 05/15/2026 | 57.00 K | $1.48 M | 100.00% | 0.29% |
| TD ASSET MANAGEMENT INC | 05/11/2026 | 47.58 K | $1.23 M | 100.00% | 0.24% |
| AMERIPRISE FINANCIAL INC | 05/15/2026 | 44.48 K | $1.15 M | 100.00% | 0.22% |
| MARSHALL WACE, LLP | 05/15/2026 | 29.35 K | $760.41 K | 100.00% | 0.15% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 28.02 K | $726.00 K | 100.00% | 0.14% |
| NORTHERN TRUST CORP | 05/14/2026 | 20.86 K | $540.53 K | 100.00% | 0.10% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 19.28 K | $499.62 K | 100.00% | 0.10% |
| STATE STREET CORP | 05/15/2026 | 17.25 K | $446.95 K | 100.00% | 0.09% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 05/15/2026 | 11.87 K | $307.55 K | 100.00% | 0.06% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 7.81 K | $202.38 K | 100.00% | 0.04% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 4.93 K | $127.66 K | 100.00% | 0.02% |
| MORGAN STANLEY | 05/15/2026 | 4.18 K | $108.28 K | 100.00% | 0.02% |
| 05/08/2026 | 3.68 K | $95.35 K | 100.00% | 0.02% | |
| UBS GROUP AG | 05/05/2026 | 455 | $11.79 K | 100.00% | 0.00% |
| BARCLAYS PLC | 05/15/2026 | 140 | $3.63 K | 100.00% | 0.00% |
| ROYAL BANK OF CANADA | 05/15/2026 | 85 | $2.00 K | 100.00% | 0.00% |
SpyGlass Pharma Inc. institutional Ownership - FAQ's
During the previous two years, 64 institutional investors and hedge funds held shares of SpyGlass Pharma Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 8.02 M
NEA Management Company, LLC: 7.39 M
Sands Capital Ventures, LLC: 2.5 M
Samsara BioCapital, LLC: 2.11 M
PRICE T ROWE ASSOCIATES INC /MD/: 704,440
Vestal Point Capital, LP: 666,760
127.23% of SpyGlass Pharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 49.78 M shares in the last 24 months. This purchase volume represents approximately $1.35 B in transactions.